Aktuelles zu Corona/Covid-19/Impfstoffe

There is no doubt that spike-inducing Covid-19 vaccines are associated with a complex and diverse range of side effects, which have significant health consequences for those affected. The known causes, primarily the activation of the renin-angiotensin-aldosterone system, as well as other induced and manipulated spike effects, are not sufficient enough to provide a plausible explanation for unusual clusters or the occurrence of rare side effects. This study aimed to investigate various adverse drug reactions that have not been observed, or have only rarely been observed, when using conventional vaccines. The analysis focused on the reaction groups following vaccination with the spike-inducing vaccines Tozinameran and Elasomeran: nervous system disorders, psychiatric disorders, musculoskeletal disorders, and general disorders. The data were retrieved from the EudraVigilance Web Reports and were interpreted based on an analysis of original research papers and review articles published in scientific journals. Among the most common adverse reactions from the aforementioned reaction groups were headaches (248,567 reports associated with Tozinameran, 90,948 reports following Elasomeran), fatigue (211,056 and 77,531 respectively), myalgia (156,735 and 62,034 respectively), asthenia (53,968 and 15,303 respectively), muscular weakness (10,882 and 3,328 respectively), anxiety/ fear (8,009 and 2,054 respectively), memory impairment/amnesia (6,475 and 2,132 respectively), depression/depressive mood (5,395 and 1,517 respectively), brain fog (3,685 and 992 respectively) and muscle twitching (3,605 and 908 respectively).
Recent findings suggest that further pathophysiological spike effects, which can significantly impair the bodys ability to maintain homeostasis, must be taken into account as possible causes. This involves an impairment of the cholinergic nervous system, which normally acts as a counter-regulatory mechanism, thereby promoting or exacerbating the undesirable activation of the renin-angiotensin-aldosterone system. Impairment of the cholinergic nervous system is caused by neurotoxin-like structures in the spike glycoprotein, which can trigger the inhibition of nicotinic-cholinergic receptors. Consequently, this can result in exacerbated inflammatory processes throughout the body, including the central nervous system. It may also result in activation of the sympathetic nervous system, thrombogenesis, pathological neuropsychiatric and musculoskeletal reactions, and an imbalance in the autonomic nervous system. Taken together, these factors may help to explain why there has been an increase in the incidence of adverse inflammatory and immunological reactions, cardiovascular reactions, coagulopathies, and neuropsychiatric and musculoskeletal disorders. However, in concrete terms, it depends on the organ-specific expression of counteracting regulators, on opposing regulatory effects, dose-dependent effects and time-dependent effects within the regulatory systems, as well as on comorbidities, age, gender, drug interactions and genetic predispositions.
Therapeutic intervention should be aimed at restoring and stabilising homeostasis. There are two main options for achieving this. Angiotensin receptor blockers are the preferred choice for inhibiting the renin-angiotensin-aldosterone system activation, specifically for counteracting the effects of the main effector, Angiotensin II. To activate and restore impaired cholinergic functions, particularly the cholinergic anti-inflammatory pathway, acetylcholine analogues, acetylcholinesterase inhibitors (e.g. donepezil and rivastigmine), and vagus nerve stimulation may be considered.

This analysis investigates mortality and relevant causes of death in Germany between 2019 and 2023, focusing particularly on the consequences of the SARS-CoV2 pandemic and mass vaccination campaigns.
Official, freely accessible annual statistics and government reports were used as sources to provide an overview of how the annual raw data has developed.
No `excess mortality` due to the pandemic in 2020 was detected that exceeded the level of the increase in deaths during the 2015 flu epidemic.
The years following the pandemic were characterised by widespread vaccination with spike-based mRNA-vaccines and basic immunisation rates exceeding 70%. Contrary to expectations, however, overall mortality increased by 3.797% in 2021 and by a further 4.31% in 2022 compared to the previous year. This represented an increase of 8.85% and 13.54% respectively compared to the pre-pandemic year. Even though the profile of the Covid-19 disease became less dangerous in the 2021 vaccination year and in the years that followed, the number of recorded deaths from the disease rose alarmingly (to 183.74% in 2021).
The available data suggest that overall mortality increased in 2021 and 2022, although the number of recorded Covid-19 deaths began to decline as early as 2022. There was a shift in the spectrum of causes of death, with an increase in fatal cardiovascular diseases, mental illnesses, and disorders of the nervous and digestive systems, and a decrease in respiratory diseases.
Given the profound mode of action of spike-based mRNA vaccines and their considerable potential for side effects, it is reasonable to suggest that they may contribute to the multifactorial causes of increased mortality.

Gleichgültig, ob durch einen „Untersuchungsausschuß“ oder eine „Enquetekommission“, es ist begrüßenswert, daß die menschengemachte Corona-Krise aufgearbeitet wird.  Die Beantwortung der Kardinalfrage, aus welchem Grund  die ungerechtfertigte Hochstufung der Gefährlichkeit der SARS-CoV2-Infektion im März 2020 erfolgte und wie es zu den katastrophal falschen Prognosen des Strategiepapiers des BMI kam, ist äußerst wichtig, denn sie lieferte den politischen Entscheidungsträgern die Argumente, die sie zur Auslösung der  unverhältnismäßigen, nicht-medizinischen Lock-Down-Maßnahmen veranlaßte. Auch die bedingte Zulassung der experimentellen unausgereiften Covid-19 Wirk-/Impfstoffe mit ihrem hohen Nebenwirkungspotential ist nur vor diesem Hintergrund möglich gewesen. Das Eintreten für eine Impfpflicht, offizielle Impfaufrufe und die Verunglimpfung von Nicht-Geimpften sind ebenso zu hinterfragen, wie die Ignoranz von Impfschäden und die Behinderung von Aufklärungsbemühungen.

Herkömmliche Impfstoffe genießen den Ruf ausreichender Effektivität und guter Verträglichkeit. Das Gegenteil erweist sich bei der Analyse von Wirksamkeit und Verträglichkeit der neuartigen, spike-basierten Covid-19 Impfstoffe (mRNA-, AdenoVirus- und proteinbasierte Wirk-/Impfstoffe). Unzureichender oder fehlender Impfschutz und insbesondere die Risiken bestimmen zunehmend den Diskurs. PEI, STIKO und die AkdÄ halten jedoch informationsresistent am Scheinkonzept eines sicheren Impfstoffes mit positiver Nutzen-Risiko-Bewertung fest. Die Vernachlässigung wissenschaftlicher Gründlichkeit und Wahrheitsfindung bei Analyse und Systematisierung der äußerst zahlreichen, vielfältigen und zum Teil gefährlichen Nebenwirkungen verhinderte den notwendigen Erkenntnisgewinn und dessen Weitergabe. Dem Gros der nicht eigenständig Recherchierenden fehlen aus diesen Gründen seit Beginn der Impfkampagne grundlegende Informationen zum Nebenwirkungsprofil und seiner Verursachung. Deshalb verwundert es nicht, daß die sogen MedSafetyWeek (4.-10.11.2024), die eine Sensibilisierung gegenüber Nebenwirkungs-meldungen  bezweckte,  für Covid-19 Impfstoffe in Deutschland gänzlich ins Leere lief.